Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
4
.jpg)
Welcome to GSK Malaysia
We provide healthcare professionals in Malaysia with relevant information on GSK products and related therapy areas, events and educational content designed to help you support your patients.
Respiratory
Discover GSK’s 40-year heritage and on-going contribution to respiratory medicine.
Vaccines
Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries.
Adverse events should be reported to drugsafetyinfo.my@gsk.com
Welcome to GSK Malaysia
We provide healthcare professionals in Malaysia with relevant information on GSK products and related therapy areas, events and educational content designed to help you support your patients.
HEAD-TO-HEAD DATA VS. ANOTHER ONCE-DAILY LAMA/LABA*
Umeclidinum/vilanterol
*Anoro showed superiority on primary endpoint of trough FEV1 compared to TIO/OLO (p<0.001) [1]
Ref 1: Feldman G.J et al. Adv Ther 2017; 34:doi 10.1007/s12325-017-0626-4
Your Online Healthcare Partner
The purpose of this web site is to support Malaysia healthcare professionals in their daily practice. It aims to provide information on GSK prescription products, our resources, latest GSK news and events.
Trade marks are owned by or licensed to the GSK group of companies
Adverse events should be reported to drugsafetyinfo.my@gsk.com
